Abstract
A phage display library of exendin-4 mutants was screened with the extracellular domain of rat glucagon-like peptide 1 receptor as the target. A novel variant of exendin-4 with higher affinity for the receptor fraction than that of the wild type was identified. The increased affinity was attributed to the substitution of Glu16 by Val16. Although the substitution probably caused an increased entropic cost to the helix region, the linker around Val16 is more flexible resulting in the increase of affinity for the receptor.
Keywords: Exendin-4, GLP-1 receptor, phage display library
Protein & Peptide Letters
Title: Screening of a Phage Display Library of Exendin-4 Mutants with the Extracellular Domain of Rat GLP-1 Receptor
Volume: 14 Issue: 8
Author(s): Xiaopu. Yin, Yushu Ma, Meiyun Liu, Weifeng Gao and Dongzhi Wei
Affiliation:
Keywords: Exendin-4, GLP-1 receptor, phage display library
Abstract: A phage display library of exendin-4 mutants was screened with the extracellular domain of rat glucagon-like peptide 1 receptor as the target. A novel variant of exendin-4 with higher affinity for the receptor fraction than that of the wild type was identified. The increased affinity was attributed to the substitution of Glu16 by Val16. Although the substitution probably caused an increased entropic cost to the helix region, the linker around Val16 is more flexible resulting in the increase of affinity for the receptor.
Export Options
About this article
Cite this article as:
Xiaopu. Yin , Yushu Ma , Meiyun Liu , Weifeng Gao and Dongzhi Wei , Screening of a Phage Display Library of Exendin-4 Mutants with the Extracellular Domain of Rat GLP-1 Receptor, Protein & Peptide Letters 2007; 14(8) . https://dx.doi.org/10.2174/092986607781483679
DOI https://dx.doi.org/10.2174/092986607781483679 |
Print ISSN 0929-8665 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5305 |

- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
- Forthcoming Thematic Issues
Related Articles
-
Schizophrenia-associated Risk and Protective Variants of c-Fos Encoding Gene
Recent Advances in DNA & Gene Sequences (Discontinued) Calcium and Vitamin D Signaling in the Epidermal Response to Wounding
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) In Vitro and In Vivo Profiles and Characterization of Insulin Nanocarriers Based in Flexible Liposomes Designed for Oral Administration
Letters in Drug Design & Discovery Structure-Activity Relationship of Supramolecular Compounds in Drug Delivery
Mini-Reviews in Organic Chemistry Herbal Drug use in Sickle Cell Disease Management; Trends and Perspectives in Sub-Saharan Africa - A Systematic Review
Current Drug Discovery Technologies Cytosolic Insulin-Binding Proteins Of Mouse Liver Cells
Protein & Peptide Letters Design, Synthesis, and Structure-Activity Relationship Study of Peroxisome Proliferator-Activated Receptor (PPAR) δ-Selective Ligands
Current Medicinal Chemistry Oral Angiotensin-(1-7) Peptide Modulates Intestinal Microbiota Improving Metabolic Profile in Obese Mice
Protein & Peptide Letters Therapeutic and Diagnostic Applications of Nanoparticles
Current Drug Targets The Pulse of Drug Development for Alzheimers Disease
Reviews on Recent Clinical Trials Astrocytes: New Targets for the Treatment of Neurodegenerative Diseases
Current Pharmaceutical Design Ethnobotanical Treatment Strategies Against Alzheimers Disease
Current Alzheimer Research Tissue Factor Modulation by Angiotensin II: A Clue to a Better Understanding of the Cardiovascular Effects of Renin-Angiotensin System Blockade?
Endocrine, Metabolic & Immune Disorders - Drug Targets Rapid and Long-Acting Analogues as an Approach to Improve Insulin Therapy: An Evidence-Based Medicine Assessment
Current Pharmaceutical Design Neuroprotective Efficacy of the Peroxisome Proliferator-Activated Receptor-γ Ligand in Chronic Cerebral Hypoperfusion
Current Neurovascular Research Current View on the Mechanism of Action of Perifosine in Cancer
Anti-Cancer Agents in Medicinal Chemistry Elevated Inflammatory Parameter Levels Negatively Impact Populations of Circulating Stem Cells (CD133+), Early Endothelial Progenitor Cells (CD133+/VEGFR2+), and Fibroblast Growth Factor in Stroke Patients
Current Neurovascular Research Haptoglobin Polymorphism and Lacunar Stroke
Current Neurovascular Research The Anti-Obesity Potential of Green Tea: The Effect on Leptin and Adiponectin
Clinical Immunology, Endocrine & Metabolic Drugs (Discontinued) Therapeutic Implications of mTOR Inhibitors in the Treatment of Gastric Cancer
Current Cancer Drug Targets